GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Q

QDM International QDMI · USD

Health Care · US listing · 🇺🇸 United States

Compare

10.90

+2.83%

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$21.5m

FY2017FY2026

Net income

$7.5m

FY2017FY2026

Free cash flow

$1.8m

FY2017FY2026

Shareholders' equity

$16.4m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$21.5m$8.4m$6.4m$1.1m$68,969$123,438————
Gross profit$11.5m$7.3m$2.5m$416,395$133$392————
Operating income$9.1m$5.9m$1.8m$42,253−$376,835−$314,475−$440,165−$60,505−$89,110−$363,038
Net income$7.5m$4.8m$1.6m$44,550−$378,165−$307,702−$467,234−$61,363−$89,110$467,136
Diluted earnings per share0.870.560.180.01-0.02-0.18-0.93-0.12-17.82173.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$17.4m$10.7m$5.8m$3.2m$270,643$151,054$2,172$89,022$228,224$258,908
Total liabilities$1.1m$1.9m$2.4m$1.3m$944,615$561,552$321,720$134,699$251,717$210,291
Debt——$1.3m$1.0m$818,700$556,500————
Shareholders' equity$16.4m$8.8m$3.4m$1.8m−$673,972−$410,498−$319,548−$45,677−$23,493$48,617
Shares outstanding9m9m9m9m21m2m1m1m0m0m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$1.8m$4.1m$2.2m$11,813−$398,610−$369,145−$132,632−$53,148−$28,324−$92,387
Capital spending——−$92,693−$17,503−$3,700−$3,700−$3,700——−$1,664
Free cash flow$1.8m$4.1m$2.1m−$5,690−$402,310−$372,845−$136,332−$53,148−$28,324−$94,051

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$8.4m$9.1m$4.8m$4.0m$3.6m$4.8m$1.6m$993,917
Gross profit$4.3m$6.9m$2.6m−$976,303$2.5m$4.3m$1.4m$884,278
Operating income$3.8m$6.4m$1.5m−$1.3m$2.2m$3.9m$908,018$610,516
Net income$3.2m$5.2m$1.3m−$1.1m$1.9m$3.2m$706,615$488,706
Diluted earnings per share0.360.600.15-0.130.220.370.080.06
Cash from operations—−$2.0m——$3.0m$2.0m——
Total assets$21.1m$17.4m$16.0m$13.8m$13.5m$10.7m$6.7m$7.0m
Shareholders' equity$19.5m$16.4m$11.2m$9.9m$11.0m$8.8m$5.7m$4.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue166.6%180.6%24.6%
Operating income500.5%——
Net income453.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.1%58.1%57.8%—
Operating margin50.4%45.2%43.2%—
Net margin41.4%37.4%35.4%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings12.226.025.4291.1-2.6-1.8-0.0-0.0
Price to sales4.315.06.311.414.34.4——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return125%329%3110%-86%1859%401%317%6300%2242%33%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 34-to-1 reverse split · 19 Sept 2025
  • 10-for-1 split · 5 Apr 2024
  • 30-to-1 reverse split · 31 Aug 2021
  • 100-to-1 reverse split · 5 May 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.